DTA-H19/PEI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DTA-H19/PEI, covering 2013-08-21 to 2013-08-21. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer [Phase 2]